FimmCyte Therapeutics
FimmCyte is a Swiss biotech developing disease modifying therapies for chronic diseases through elimination of diseased cells directly. FimmCyte has a pipeline of multi-specifics with the two most advanced assets ready for IND and CMC for endometriosis and an organ fibrosis.
Date, time and room information
May 6, 12:45 - 13:00, room Singapore
Category
Emerging biotech company
Title of the presentation
Disease Modifying Therapies for Chronic Fibro-inflammatory Disease
Speaker information
| Name | Position | Institution |
|---|---|---|
| Dr. Mohaned Shilaih | CEO | FimmCyte Therapeutics |
Host and event manager:
Logistics and marketing partner:
